SCHEMBL23533404

SCHEMBL23533404

CCCCCC1CC(C(=O)O)(C(=O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.42
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.37
CYP1A2 P05177 2/20 0.37
AKR1B1 P15121 1/20 0.37
S1PR3 Q99500 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GPR84 Q9NQS5 2/20 0.35
PPARG P37231 2/20 0.35
PPARD Q03181 2/20 0.35
PPARA Q07869 2/20 0.35
TSHR P16473 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8774500 0.98 ALOX5 (0.44) ALOX5TP53S1PR3ALDH1A1MEN1
SCHEMBL11343623 0.85 FYN (0.36) ALDH1A1MAPTCYP2C9
SCHEMBL23533398 0.81 CA1 (0.42) ALOX5PKMCYP1A2MEN1HTT
SCHEMBL8773998 0.81 ALOX5 (0.40) ALOX5TP53PKMCYP1A2AKR1B1
SCHEMBL4868042 0.80 MAPT (0.36) TP53CYP1A2ALDH1A1MAPTHTT
SCHEMBL8774071 0.79 ALOX5 (0.42) ALOX5TP53S1PR3ALDH1A1MEN1
SCHEMBL23533298 0.78 ALDH1A1 (0.40) ALOX5TP53PKMCYP1A2ALDH1A1
SCHEMBL11461941 0.77 SIGMAR1 (0.47) CYP1A2GPR84
SCHEMBL11480012 0.74 CYP1A2 (0.42) CYP1A2
SCHEMBL8774101 0.74 MAPT (0.39) ALOX5TP53CYP1A2AKR1B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230107538-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2023-04-06 US disclosed
US-20230107538-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2023-04-06 US disclosed
EP-4076649-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2022-10-26 EP disclosed
CN-114828958-A Cycloalkyl-containing carboxylic acids and use thereof 里米诺生物科学有限公司 2022-07-29 CN disclosed
WO-2021124272-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF Liminal Biosciences Limited (GB) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230107538-A1 CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF HCCS, CCL11, BCAT1 ALOX5 120/4885TP53 1332/4885PKM 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.